<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04215627</url>
  </required_header>
  <id_info>
    <org_study_id>Biobeat004</org_study_id>
    <nct_id>NCT04215627</nct_id>
  </id_info>
  <brief_title>Comparing the PiCCO Monitor to the Non-invasive Biobeat (BB)-316PW in ICU Patients</brief_title>
  <official_title>Comparison Between Invasive Hemodynamic Monitoring, Using the PiCCO Monitor, to a Non-invasive Photoplethysmography Based Device in Hemodynamic Unstable Critically Ill Patients, With Vasopressor Support</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biobeat Technologies Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Assaf-Harofeh Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Biobeat Technologies Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare hemodynamic monitoring using the invasive PiCCO device to&#xD;
      the BB-613PW wireless, non-invasive PPG-based device, in critically ill patients within the&#xD;
      ICU, suffering from hemodynamic instability and in need of vasopressor support. Data will be&#xD;
      gathered prospectively and analysed retrospectively.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 26, 2019</start_date>
  <completion_date type="Actual">April 30, 2021</completion_date>
  <primary_completion_date type="Actual">April 15, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Level of accordance between the BB-613PW to the PiCCO</measure>
    <time_frame>72 hours per individual</time_frame>
    <description>We will compare the level of accordance of blood pressure, heart rate, stroke volume, cardiac output, heart rate variability, and systemic vascular resistance.</description>
  </primary_outcome>
  <enrollment type="Actual">9</enrollment>
  <condition>Critically Ill</condition>
  <condition>Hemodynamic Instability</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>non-invasive monitoring</intervention_name>
    <description>Comparing the PiCCO monitor to the non-invasive BB-613PW device in hemodynamically unstable critically ill patients in the ICU</description>
    <other_name>BB-613PW</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients admitted to the ICU unit, suffering from shock and in need for vasopressor&#xD;
        support of more than 0.2 mcg/Kg/Min for a period longer than 3 hours, and that the treating&#xD;
        physician has decided there is a need to insert a PiCCO catheter for invasive monitoring of&#xD;
        their hemodynamic condition. Total period of monitoring will be up to 72 hours.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ICU adult patients in the need of vasopressor support of more than 0.2 mcg/Kg/Min for&#xD;
             a period longer than 3 hours&#xD;
&#xD;
          -  Patients in which PiCCO monitoring is needed&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Refusal of the subject&#xD;
&#xD;
          -  Technical difficulties in insertion of the PiCCO catheters&#xD;
&#xD;
          -  Significant cardiac arrhythmias&#xD;
&#xD;
          -  Significant valvular disease&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Ayana Dvir, MD, MHA</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Assaf Harofeh Medical Center, Tzrifin, Israel</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Assaf Harofeh Medical Center, Zrifin</name>
      <address>
        <city>Rishon LeZion</city>
        <zip>70300</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>December 29, 2019</study_first_submitted>
  <study_first_submitted_qc>December 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 2, 2020</study_first_posted>
  <last_update_submitted>July 4, 2021</last_update_submitted>
  <last_update_submitted_qc>July 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Critically Ill patients</keyword>
  <keyword>blood pressure</keyword>
  <keyword>vital signs</keyword>
  <keyword>non-invasive monitoring</keyword>
  <keyword>Vasopressor support</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>We plan to share the anonymised data within a manuscript (both analysed data and the raw vital sign data).</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

